Read about current news and trends in Salmonella research in
the latest APUA Newsletter 




 

"I think its fascinating what they've accomplished" - states APUA President Dr. Stuart Levy in the Boston Globe on a recent antibiotic discovery. 

Read the full article here.  

 

 


Antibiotics are humanity's key defense against disease-causing microbes. The growing prevalence of antibiotic resistance threatens a future where these drugs can no longer cure infections and killer epidemics run rampant. The Alliance for the Prudent Use of Antibiotics (APUA) has been the leading global non-governmental organization fighting to preserve the effectiveness of antimicrobial drugs since 1981. With affiliated chapters in over 66 developed and developing countries, we conduct research, education and advocacy programs to control antimicrobial resistance and ensure access to effective antibiotics for current and future generations. For more information on antibiotic resistance research, visit our partner lab at the Center for Adaptation Genetics and Drug Resistance.

Antibiotic Resistance
in the News





2014 PCAST Report on 
Combating Antimicrobial Resistance





The 2014 WHO Report on
Antimicrobial Resistance:



 
The 2013 CDC Report:
 
 
 

 

  


 

Public Health AdvocacyGlobal Research and Survellience

Consumer and Practioner ResourcesAPUA Chapters



"Antibiotics are uniquely societal drugs because individual use affects others in the community and environment.  Better stewardship, incentives, and establishment of a special regulatory category will improve how they are used, marketed, and developed through incentives to industry."


Stuart B. Levy, M.D.
President of APUA, professor at Tufts University School of Medicine

From the IOM 25th Anniversary Symposium (1996) and The Antibiotic Paradox (2002)

2014 Alliance for the Prudent Use of Antibiotics | 136 Harrison Ave, M&V Suite 811, Boston, MA, 02111 | Tel 617.636.0966 | apua@tufts.eduHome | Search | Contact Us